code of conduct interfarma review 2012 - global health care · code of conduct interfarma. review...

“Segundo Congreso Latinoamericano de Compliance de la Industria Farmacéutica e Insumos para la Salud, y el Foro de Buenas Prácticas”

Code of Conduct InterfarmaReview 2012

Federal Council of Medicine

Brazilian Medical Association

Brazilian Society of Cardiology

CODE OF CONDUCT - REVIEW 2012Guidelines for Good Relationship Practices with the Brazilian medical community, public officials and

pacient associations

Interfarma has a cooperation agreement between the partners listed below

Brazilian Society of Pharmaceutical Medicine

Brazilian Association of distributors of special and exceptional medicines Oncoguia institute

Signed a partnership with Interfarma - Code of Conduct

1968

IFPMA was establishedInternational Federation of

Pharmaceutical Manufacturers & Associations

1986

1990

2007

2008

2012

IFPMACode of Practice was established

INTERFARMA was foundedBrazilian Research-based

Pharmaceutical Manufactures Association

INTERFARMAInterfarma’s Code of Conduct was written based on IFPMA’s

Code of Practice - 2006

INTERFARMACode of Conduct

first review

INTERFARMAThe Agreement’s content becomes part of the new

Code



2012

INTERFARMA4 MODULES TRAINING

INDUSTRYCUSTOM

METHODOLOGY

TRAININGCODE CERTIFICATIONDISSEMINATION

PROMOTION COMMUNICATION

AND PUBLICITY

MOBILIZATIONAWARENESS AND

RECOGNITION



CAUSEGUIDELINES FOR GOOD

RELATIONSHIP PRACTICES

WITH THE BRAZILIAN MEDICAL

COMMUNITY, PUBLIC

OFFICIALS, PACIENT

ASSOCIATIONS, INSTITUTIONS,

AND COMPANIES OF THE

SECTOR

EFFECTCOMPLETED

CERTIFICATION PROCESS IDENTIFIER

BIOME53 ASSOCIATED COMPANIES



AGREEMENTS FOR THE CODE OF CONDUCT:IT IS NOT THE END OF THE PROCESS

IT IS JUST THE BEGINNING.



STRUCTURE OF THE CODE



GENERAL RULES FOR THE PHARMACEUTICAL SECTOR

SECTION 11DISTRIBUTION OF FREE SAMPLES

SECTION 12VISIT TO HEALTHECARE PROFESSIONALS

SECTION 13DONATIONS AND OTHER CONTRIBUTION FOR HEALTHCARE INSTITUTIONS, BODIES, ASSOCIATIONS AND COMPANIES

RULES RELATED TO DRUGS

SUBJECT TO A PHYSICIAN’S

PRESCRIPTION

SECTION 14OVER-THE-COUNTER

DRUGS (OTC)

SECTION 15DIRECT CONTACT WITH

CONSUMERS

RULES RELATED TO OVER-

THE-COUNTER DRUGS (OTC)SECTION 16

APPLICATION AND EFFECTIVENESS OF CODE

OF CONDUCT RULES

SECTION 17ETHICS COMMITTEE

SECTION 18PENALTIES

RULES FOR THE CONFLICT RESOLUTION

SECTION 1FUNDAMENTAL

PRINCIPLES

SECTION 2RELATIONSHIP WITH PUBLIC

OFFICIALS AND GOVERNMENT AUTHORITIES

SECTION 3INTERACTIONS AND

RELATIONSHIP WITH PACIENT ASSOCIATIONS

SECTION 4ADHENCE TO THE CODE AND ENFORCEMENT IN HEALTHCARE RELATED

AREAS

SECTION 5CONTRACTING OF

SPECIALIZED SERVICES IN HEALTHCARE

SECTION 6CONGRESS, SYMPOSIUMS,

SEMINARS AND OTHER EVENTS

SECTION 7PROMOCIONAL MATERIALS

SECTION 8DRUG-RELATED ACTIVITIES AT

POINTS OF SALES

SECTION 9COMMUNICATION ON NEW DRUGS AND INDICATIONS NOT APPROVED

BY ANVISA (OFF LABEL)

SECTION 10OFFER OF GIFTS



This notice was published

in the Onco &

journal, Pharma Up magazine, Braz

ilian

Society of Cardiology jour

nal, AMB Journal

and in the SNIF Doctor we

bsite.Was distributed

to approximately

45.000 doctors



CODE OF CONDUCT: THE CAMPAIGN “I FOLLOW IT”

EXCEEDS 20 MIL CERTIFICATES21.500 employees of member companies have completed the training. The following companies have already completed the training: ABBOTT, ACTELION, ALEXION, ALLERGAN, AMGEN, ASTELLAS, ASTRAZENECA, BAGO,

BAYER, BAXTER, BESINS, BIOGEN IDEC, BIOMARIN, BMS, BOEHRINGER, CELGENE, CHIESI, DAIICHI SANKYO, FERRING, GALDERMA, GE HEALTHCARE, GENZYME, GLAXOSMITHKLINE, GRUNENTHAL, IPSEN, ISDIN, JANSSEN, LEO PHARMA S.A., LILLY, LUNDBECK, MERCK S.A, MSD, MUNDIPHARMA, NOVARTIS, NOVO NORDISK, PFIZER, PIERRE FABRE, ROCHE, SANOFI, SERVIER, SHIRE, STIEFEL (GLAXOSMITHKLINE), TAKEDA, THERASKIN, ZAMBON.

Link for access to the training: http://codigodeconduta.webmeeting.com.br Link to access Interfarma’s website : http://www.interfarma.org.br/codigo_conduta.php

Webmeeting covered 58 different cities 60% of the

participants were sales

reps



Número do WebMeeting:

W12834

Senha para acesso:

WR6A4

Or visit www.webmeeting.com.br and enter the information above

August 19: webmeeting with doctors, with the presence of Dr. Florentino CardosoAugust 19: webmeeting with doctors, with the presence of Dr. Florentino Cardoso

The number of accesses to the live encounter was around 295

hits of 113

cities and 20

different states, and there was an access from Mexico. Like the last, about 60%

of the participants consisted of the sales force teams. The medical interest was about 24%, and 8% and 7%

of pharmaceuticals associated or not to other industry fields. In addition, 22

questions about the Code of Conduct and the relationship between the pharmaceutical industry and the medical classes were asked and answered during the meeting.



805 people have already seen Interfarma’s

webmeetings

CODE OF CONDUCT: “I FOLLOW IT DAY”



THANK YOU!MARIA JOSÉ DELGADO FAGUNDES

[email protected]

The images contained in here are restricted to this presentation

http://www.interfarma.org.br/

code of conduct interfarma review 2012 - global health care · code of conduct interfarma. review...

Documents